Sep 6, 2023 ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 14, 2023 ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlights
Jul 17, 2023 ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s Pipeline
Jun 29, 2023 CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern Time
May 15, 2023 ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights
May 8, 2023 ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease